Pricing Log in Create free account

Longeveron Inc. (LGVN) vs Pulmatrix, Inc. (PULM)

Longeveron Inc. and Pulmatrix, Inc. are both Biotechnology companies. Longeveron Inc. and Pulmatrix, Inc. are of similar size ($5.2M and $4.8M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against −42.7%. Pulmatrix, Inc. has the higher net margin (0.00% vs −1,977.6%) and the higher return on invested capital (0.00% vs −4,549.0%). Across the 17 metrics below, Pulmatrix, Inc. leads on 13 and Longeveron Inc. on 4.

Valuation

Metric LGVN PULM Biotechnology median
P/E n/m n/m 8.50
P/S 3.67 0.64 9.71
P/B 0.42 3.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.22 n/m 0.64
EV/Sales (4.16) 0.82 9.21
Earnings yield (712.23%) (80.88%) (33.15%)
Free cash flow yield (477.81%) (86.74%) (25.50%)

Profitability

Metric LGVN PULM Biotechnology median
Gross margin 69.76% 100.00% 65.16%
Operating margin (1,992.84%) 0.00% 0.00%
Net margin (1,977.59%) 0.00% 0.00%
Free cash flow margin (1,755.69%) 0.00% 0.00%
Return on equity (203.61%) (111.99%) (56.36%)
Return on assets (145.64%) (85.74%) (48.04%)
Return on invested capital (4,549.04%) 0.00% 0.00%

Growth

Metric LGVN PULM Biotechnology median
Revenue growth (TTM) (42.74%) 6.96% 6.02%
EPS growth (last fiscal year) 50.76% 46.18% 30.26%
Revenue growth, 5-year CAGR (26.60%) (0.26%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LGVN PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.63 4.70 4.72
Net debt to EBITDA 0.20 0.79 0.96

Dividend

Metric LGVN PULM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LGVN PULM Biotechnology median
Market cap 4.79m 5.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack